Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX). [electronic resource]
Producer: 20200403Description: 577-590 p. digitalISSN:- 1776-260X
- Adenocarcinoma -- drug therapy
- Animals
- Antineoplastic Agents, Immunological -- therapeutic use
- Colorectal Neoplasms -- drug therapy
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Gene Expression Regulation, Neoplastic
- Genetic Engineering
- HCT116 Cells
- Heterografts
- Humans
- Immunoconjugates -- therapeutic use
- Immunotherapy -- methods
- Lung Neoplasms -- drug therapy
- Membrane Proteins -- genetics
- Mice
- Molecular Targeted Therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.